OMER

Omeros
OMER

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$289.24M
EV
$642.50M
Shares Outstanding
68.06M
Beta
2.26

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$22.50
P/E 2025E
-
P/Revenue 2025E
111.05x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Omeros Corporation

gainify
OMER

Omeros Corporation

OMER

Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases, including complement-mediated diseases, cancers, and addictive and c...

Sector

Healthcare

Industry

Biotechnology

CEO

Demopulos, Gregory

Employees

202

IPO Date

2009-10-08

Headquarters

The Omeros Building, 201 Elliott Avenue West, Seattle, Washington, 98119, United States

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.